ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.96307
-0.05%
Brent Oil
82.87
-0.91%
Bitcoin
62,041.54
4.94%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/05/202415:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABCAmerisourceBergen Corp
03/05/202415:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AAM-BApollo Asset Management Inc
03/05/202415:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:APTV-AAptiv PLC
03/05/202415:02PR Newswire (US)Steller Wins TravelTech's 2024 AI Innovation of the Year
03/05/202415:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
03/05/202415:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TMKRUPriveterra Acquisition Corporation II
03/05/202415:01Business WireAtara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
03/05/202415:01Business WireOmnicell to Present at the BofA Securities 2024 Health Care ConferenceNASDAQ:OMCLOmnicell Inc
03/05/202415:01PR Newswire (US)Sunoco LP Announces Purchase of NuStar Preferred Units and Full Redemption of NuStar Logistics Subordinated NotesNYSE:SUNSunoco LP
03/05/202415:01Business WireOSI Systems to Present at Oppenheimer 19th Annual Industrial Growth ConferenceNASDAQ:OSISOSI Systems Inc
03/05/202415:01GlobeNewswire Inc.Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VERVVerve Therapeutics Inc
03/05/202415:01GlobeNewswire Inc.S Split Corp. Declares Monthly DistributionSBN-PR
03/05/202415:01GlobeNewswire Inc.NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NAMSNewAmsterdam Pharma Company NV
03/05/202415:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
03/05/202415:01GlobeNewswire Inc.Infinite Reality’s SPAC Partner Engages BTIG as Capital Markets Advisor; Continues to Drive Robust Expansion and Strengthened Market PositionNASDAQ:NBSTNewbury Street Acquisition Corporation
03/05/202415:01GlobeNewswire Inc.Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly DistributionTSX:CBNKMulvihill Canadian Bank Enhanced Yield ETF
03/05/202415:01GlobeNewswire Inc.Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly DistributionTSX:XLVEMulvihill US Health Care Enhanced Yield ETF
03/05/202415:01GlobeNewswire Inc.Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for its ETF ClassTSX:MPYMulvihill Premium Yield Fund
03/05/202415:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CHAACatcha Investment Corp
03/05/202415:00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
03/05/202415:00GlobeNewswire Inc.Studies Find Disparities in Urologic Cancer Diagnosis and Care for Black Americans
03/05/202415:00GlobeNewswire Inc.Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MURAMural Oncology PLC
03/05/202415:00GlobeNewswire Inc.OriginTrail Decentralized Knowledge Graph for trusted cross-organization real-time data integration in EU-funded DMaaST
03/05/202415:00GlobeNewswire Inc.Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ARQTArcutis Biotherapeutics Inc
03/05/202415:00PR Newswire (US)The Iconic Caribbean Posh Weekend Returns To The USVI; Will Honor Dr. Yvette Noel-Schure
03/05/202415:00PR Newswire (US)S&P Global to Present at the Barclays Americas Select Franchise Conference on May 7, 2024NYSE:SPGIS&P Global Inc
03/05/202415:00PR Newswire (US)Adler Entertainment Trust Publishes a Trio of New Books
03/05/202414:59PR Newswire (Canada)Transport scolaire - Entente de principe conclue et acceptée chez Autobus B. Dion
03/05/202414:55PR Newswire (US)Atlanta Housing Honored with National Association of Local Housing Finance Agencies Award of Excellence
03/05/202414:52Business WirePrism Visual Software Acquires Advantage Route Systems

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
NYSE
AXP
American Express
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
NYSE
MRK
Merck
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
CCOM
OILBRENT
Brent Oil
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados